MedPath

Water Intake and Weight Control in Older Adults

Not Applicable
Recruiting
Conditions
Overweight and Obesity
Interventions
Behavioral: Water intake and weight control in older adults - Premeal Water + hypocaloric diet
Behavioral: Water Intake and weight control in older adults - hypocaloric diet alone
Behavioral: Water intake and weight control in older adults - Total Daily Water + hypocaloric diet
Registration Number
NCT05843318
Lead Sponsor
Virginia Polytechnic Institute and State University
Brief Summary

This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout the day with a hypocaloric diet; 3) hypocaloric diet with no instructions regarding water consumption. Smart water bottles will objectively assess water intake timing and volume. Urine osmolality, urine volume, and serum osmolality will be used as objective indicators of compliance with the water intake prescription. We will investigate changes in perceived hunger and fullness and appetite-regulating hormones as potential mechanisms by which premeal water could improve appetite regulation. We will also investigate the impact of water consumption and hydration on executive function capabilities, which may influence intervention adherence. Although increasing water intake could be an effective weight management strategy, no evidence-based recommendations exist for the timing of water intake needed for this benefit.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
375
Inclusion Criteria
  • aged 50+ years
  • BMI ≥25 kg/m2
  • weight stable (+/- 2 kg) in past 6 months
  • willing to provide consent and comply with study protocol
Read More
Exclusion Criteria
  • usual plain drinking water intake >1500 ml/d
  • uncontrolled hypertension (>159/99 mmHg)
  • medical condition requiring specialized diet prescription (eg, T2D, CHF wih fluid restriction)
  • medical condition that precludes participating in a physical activity program (eg, orthopedic injury)
  • current or history of GI disease (eg, Crohn's), GI surgery, or medications which impact GI function
  • allergies or aversions to foods included in the test meals
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pre-meal water + Hypocaloric dietWater intake and weight control in older adults - Premeal Water + hypocaloric dietpremeal water ( 500 ml) before each main meal, three times per day + hypocaloric diet
Hypocaloric Diet aloneWater Intake and weight control in older adults - hypocaloric diet alonehypocaloric diet with not instructions regarding water intake
Daily water + Hypocaloric dietWater intake and weight control in older adults - Total Daily Water + hypocaloric diettotal daily water prescription (1500 ml/d) + hypocaloric diet
Primary Outcome Measures
NameTimeMethod
Body weight changeweeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Body weight change in weight loss and weight loss maintenance phases

Secondary Outcome Measures
NameTimeMethod
Change in hydration statusweeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Changes in hydration status, assessed using urine and serum osmolality, urine specific gravity, and serum sodium, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.

Change in appetite sensationsweeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Changes in hunger and fullness, assessed using 100mm Visual Analog Scales (VAS), in weight loss and weight loss maintenance phases. These changes may mediate adherence to the hypocaloric diet and weight loss outcomes.

Change in executive function (EF)weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Changes in EF (attention, inhibition) assessed using ePRIME computerized tasks, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.

Trial Locations

Locations (1)

Virginia Tech

🇺🇸

Blacksburg, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath